Influence of grapefruit juice on scopolamine pharmacokinetics and pharmacodynamics in healthy male and female subjects

International Journal of Clinical Pharmacology and Therapeutics

Volumn 38, Issue 11, 2000, Pages 523-531

  Ebert, U ^a   Oertel, R ^a   Kirch, W ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Gender; Grapefruit juice; Pharmacodynamics; Pharmacokinetics; Scopolamine

Indexed keywords

CYTOCHROME P450; SCOPOLAMINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DEMETHYLATION; DRUG BIOAVAILABILITY; DRUG ELIMINATION; DRUG METABOLISM; DRUG UPTAKE; FEMALE; FOOD DRUG INTERACTION; FRUIT JUICE; GENDER; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; SEX DIFFERENCE;

EID: 0033761923     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP38523     Document Type: Article

References (45)

1. Drug interactions with grapefruit juice
2. Interaction of citrus juices with felodipine and nifedipine
3. Grapefruit juice and drugs. How significant is the interaction?
4. The use of analogue scales in rating subjective feelings
5. Effect of oral Contraceptives on drug metabolism
6. Effect of oral contraceptives on plasma clearance
7. Dextromethorphan as an in vivo probe for the simultaneous determination of CYP2D6 and CYP3A activity
8. Pharmacokinetics and pharmacodynamics of scopolamine after subcutaneous administration
9. Effects of physostigmine on scopolamine-induced changes in quantitative electroencephalogram and cognitive performance
10. Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2-dependent metabolism of caffeine in man
11. The fate of naringin in humans: A key to grapefruit juice-drug interactions?
12. Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance
13. Studies on human memory: The interaction of diazepam, scopolamine, and physostigmine
14. Non-compartmental analysis based on statistical moment theory
15. Anticholinergics
16. Diazcpam disposition determinants
17. Effect of age and gender on the activity of human hepatic CYP3A
18. Influence of gender and menopause on gastric emptying and motility
19. Effect of grapefruit juice on the pharmacokinetics of amlodipine in healthy volunteers
20. Effects of norethynodrel and progesterone on hepatic drug-metabolizing enzyme systems
21. Atropine metabolism in man
22. Pharmacokinetics of scopolamine during caesarean section: Relationship between serum concentration and effect
23. Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs
24. Characterization of the human cytochrome P-450 enzymes involved in the metabolism of dihydrocodeine
25. Expression of CYP3A4, CYP3A5 and CYP3A7 in human duodenal tissue
26. Pharmacokinetics of intravenous scopolamine in healthy young male and female volunteers
27. Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel, Lack of prediction by the erythromycin breath test
28. A comparison of plasma levels of hyoscine after oral and transdermal administration
29. Determination of scopolamine in human serum by gas chromatography-ion trap tandem mass spectrometry
30. Toxic alkaloids and their interaction with microsomal cytochrome P-450 in vitro
31. Identification of the rabbit and human cytochromes P-450IIIA as the major enzymes involved in the N-demethylation of diltiazem
32. Pharmacokinetics and oral bioavailability of scopolamine in normal subjects
33. Bioavailability of intranasal scopolamine in normal subjects
34. Demethylation of tertiary amines by a reconstituted cytochrome P-450 enzyme system: Kinetics of oxygen consumption and hydrogen peroxide formation
35. Oxidative metabolism of clarithromycin in the presence of human liver microsomes. Major role for the cytochrome P-4503A (CYP3A) subfamily
36. Effects of scopolamine (0.25-20 - 0.75 mg i.m.) on the quantitative EEG and the neuropsychological status of healthy volunteers
37. Anticholinergic drug effects on quantitative electroencephalogram, visuelly evoked potential, and verbal memory
38. The influence of pregnancy and oral contraceptive steroids on the concentration of plasma proteins
39. Influence of gender on the pharmacokinetics and pharmacodynamics of drugs
40. Metabolism in vivo of the tropane alkaloid, scopolamine, in several mammalian species
41. Untersuchungen zum Stoffwechsel yon Tropan-Alkaloiden. 8. Chemische Analyse des Stoffwechsels von (-)-Scopolamin bei einigen Saugetieren
42. An investigation of the range of cognitive impairments induced by scopolamine-0.6 mg s.c.
43. Alzheimer's disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
44. Sex-related differences in drug disposttion in man
45. Identification of cytochrome P-4503A as the major enzyme subfamily responsible for the metabolism of 22,23-dihydro-13-O-[2-methoxyethoxy]-avermectin B1 aglycone by rat liver microsomeS